Augmented production of chemokines by the interaction of type II collagen-reactive T cells with rheumatoid synovial fibroblasts. 2004

Do-June Min, and Mi-La Cho, and Sang-Heon Lee, and So-Youn Min, and Wan-Uk Kim, and Jun-Ki Min, and Sung-Hwan Park, and Chul-Soo Cho, and Ho-Youn Kim
Catholic Research Institutes of Medical Sciences, Catholic University of Korea, Seoul, Korea.

OBJECTIVE To determine the impact of type II collagen (CII)-reactive T cells on the production of chemokines in the joints of patients with rheumatoid arthritis (RA). METHODS T cell proliferative responses to bovine CII were assayed in synovial fluid (SF) mononuclear cells and peripheral blood mononuclear cells. CII-stimulated T cells were cocultured with fibroblast-like synoviocytes (FLS). The expression of interleukin-8 (IL-8), monocyte chemoattractant protein 1 (MCP-1), and macrophage inflammatory protein 1 alpha (MIP-1 alpha) in the sera, SF, and supernatant of the CII-stimulated T cells and FLS coculture was measured by enzyme-linked immunosorbent assays. RESULTS The levels of IL-8, MCP-1, and MIP-1 alpha in SF were significantly higher than those in paired sera of RA patients. IL-8, MCP-1, and MIP-1 alpha levels in SF were strongly correlated with T cell responses to CII. When FLS were cocultured with CII-stimulated T cells, the production of IL-8, MCP-1, and MIP-1 alpha was significantly increased. This increase correlated well with the T cell proliferative response to CII. Chemokine production by coculture of CII-stimulated T cells and FLS was mediated mainly by direct cell-cell contact through CD40 ligand-CD40 engagement. CONCLUSIONS Our data indicate that the presence of CII-reactive T cells in RA joints can increase the production of chemokines such as IL-8, MCP-1, and MIP-1 alpha through interaction with FLS. This chemokine production is mediated by cell-cell contact, including CD40 ligand-CD40 engagement. These results suggest that CII-reactive T cells play a crucial role in the amplification and perpetuation of the inflammatory process in the rheumatoid synovium.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002450 Cell Communication Any of several ways in which living cells of an organism communicate with one another, whether by direct contact between cells or by means of chemical signals carried by neurotransmitter substances, hormones, and cyclic AMP. Cell Interaction,Cell-to-Cell Interaction,Cell Communications,Cell Interactions,Cell to Cell Interaction,Cell-to-Cell Interactions,Communication, Cell,Communications, Cell,Interaction, Cell,Interaction, Cell-to-Cell,Interactions, Cell,Interactions, Cell-to-Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005260 Female Females
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal

Related Publications

Do-June Min, and Mi-La Cho, and Sang-Heon Lee, and So-Youn Min, and Wan-Uk Kim, and Jun-Ki Min, and Sung-Hwan Park, and Chul-Soo Cho, and Ho-Youn Kim
March 2000, The Journal of rheumatology,
Do-June Min, and Mi-La Cho, and Sang-Heon Lee, and So-Youn Min, and Wan-Uk Kim, and Jun-Ki Min, and Sung-Hwan Park, and Chul-Soo Cho, and Ho-Youn Kim
June 2005, Rheumatology international,
Do-June Min, and Mi-La Cho, and Sang-Heon Lee, and So-Youn Min, and Wan-Uk Kim, and Jun-Ki Min, and Sung-Hwan Park, and Chul-Soo Cho, and Ho-Youn Kim
December 1986, Scandinavian journal of immunology,
Do-June Min, and Mi-La Cho, and Sang-Heon Lee, and So-Youn Min, and Wan-Uk Kim, and Jun-Ki Min, and Sung-Hwan Park, and Chul-Soo Cho, and Ho-Youn Kim
January 2006, Modern rheumatology,
Do-June Min, and Mi-La Cho, and Sang-Heon Lee, and So-Youn Min, and Wan-Uk Kim, and Jun-Ki Min, and Sung-Hwan Park, and Chul-Soo Cho, and Ho-Youn Kim
January 1978, Arthritis and rheumatism,
Do-June Min, and Mi-La Cho, and Sang-Heon Lee, and So-Youn Min, and Wan-Uk Kim, and Jun-Ki Min, and Sung-Hwan Park, and Chul-Soo Cho, and Ho-Youn Kim
February 1986, Journal of immunology (Baltimore, Md. : 1950),
Do-June Min, and Mi-La Cho, and Sang-Heon Lee, and So-Youn Min, and Wan-Uk Kim, and Jun-Ki Min, and Sung-Hwan Park, and Chul-Soo Cho, and Ho-Youn Kim
March 1999, Rheumatology (Oxford, England),
Do-June Min, and Mi-La Cho, and Sang-Heon Lee, and So-Youn Min, and Wan-Uk Kim, and Jun-Ki Min, and Sung-Hwan Park, and Chul-Soo Cho, and Ho-Youn Kim
February 1995, Immunology letters,
Do-June Min, and Mi-La Cho, and Sang-Heon Lee, and So-Youn Min, and Wan-Uk Kim, and Jun-Ki Min, and Sung-Hwan Park, and Chul-Soo Cho, and Ho-Youn Kim
January 2009, Biochemical and biophysical research communications,
Do-June Min, and Mi-La Cho, and Sang-Heon Lee, and So-Youn Min, and Wan-Uk Kim, and Jun-Ki Min, and Sung-Hwan Park, and Chul-Soo Cho, and Ho-Youn Kim
January 1989, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!